Buscopan Inject, Injektionslösung

7680173520258 CH-17352 Injektionslösung
Buscopan Inject, Injektionslösung
Buscopan Inject, Injektionslösung
Buscopan Inject, Injektionslösung
1 / 3
google

Article details

Package size
5
Selling units
5
Measure
Ampulle(n)
Galenic form
Injektionslösung
Galenic group
Injektion/Infusion

Official Swissmedic V2 data

Additional information from the official database

Official medical documents

Summary of Product Characteristics
Allemand
01/11/2024
Summary of Product Characteristics
Français
01/11/2024
Summary of Product Characteristics
Italien
01/11/2024

Detailed composition

Substance Quantity Type Category
(N/A)
20.0 MG Substance Wirkstoff (Principe actif)
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
natrium
2.36 MG Substance HBESI

Reimbursement information

Public price
CHF 12.55
Specialties list
Yes
Generic
No
SL addition date: 01/04/2009

Authorization holder

Opella Healthcare Switzerland AG

6343 Risch

Authorization information

Swissmedic authorization number
17352
Drug name
Buscopan Inject, Injektionslösung
Galenic form
LSPA
ATC Code
A03BB01
Authorization status
Z
Dispensing category
B
First authorization
14/06/1952
Authorization expiration date
31/12/9999
IT Number
04.02.0.
Domain
Human medicine
Field of application
Spasmolyticum

Package details

Description (FR)
BUSCOPAN Inject sol inj 20 mg/ml 5 amp 1 ml
Description (DE)
BUSCOPAN Inject Inj Lös 20 mg/ml 5 Amp 1 ml
Market launch
14/06/1952
Narcotic (BTM)
No

Other package sizes (1)

BUSCOPAN sol inj 20 mg 5 amp 1 ml
None None
GTIN: 7680173520241
Not in V1